News

The latest press releases, publications, and events for Innoviva Specialty Therapeutics

Filter by:

All News Press Releases Events

06.03.2023

Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients

Read More

06.03.2023

Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial

Read More

08.14.2021

Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study

Read More

03.18.2021

Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients

Read More

11.24.2020

A Multicenter Observational Cohort Study of Angiotensin II in Shock

Read More

08.31.2020

Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use

Read More

08.31.2020

Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury

Read More

08.29.2020

Angiotensin II for Critically Ill Patients With Shock After Heart Transplant

Read More

08.07.2020

Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study

Read More

07.01.2020

Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock

Read More